Cervical cancer is by far the most common HPV-related disease. About 99.7% of cervical
cancer cases are caused by persistent genital high-risk human papillomavirus (HPV) …

This review is an abbreviated version of a report prepared for the American Cancer Society
Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt …

Bionanotechnology has pivotal role in the development of a novel therapy, applications of
gold nanoparticles (AuNPs) in the treatment of cancer. In this study, we found that …

Importance The World Health Organization is developing a global strategy to eliminate
cervical cancer, with goals for screening prevalence among women aged 30 through 49 …

Cytology-based cervical screening had unequivocal success in reducing the incidence and
mortality of cervical cancer in the last century. The recognition of the role of human …

Background Human papillomavirus (HPV) testing on self-samples represents a great
opportunity to increase cervical cancer screening uptake among under-screened women …

Highlights•Gold nanoparticles (AuNPs) have been utilized in the treatment of various types
of cancer.•AuNPs have excellent photochemical and surface properties.•The properties of …

Abstract Background Cervical cancer in Saudi Arabia is ranked as the third most frequent
gynecological cancer among women. The Pap smear test is a screening test that can be …

To evaluate the Turkey's nationwide HPV DNA screening program on the basis of first 1
million screened women. Women over age 30 were invited for population based screening …

Cervical cancer is a leading cause of morbidity and mortality in women worldwide. The
availability of prophylactic vaccines for high-risk types of human papillomavirus (HPV) …